Leather H Alex, Ver Eycken Kirsten, Segers Patrick, Herijgers Paul, Vandermeersch Eugène, Wouters Patrick F
Center for Experimental Surgery and Anesthesiology, Department of Anesthesiology, Katholieke Universiteit Leuven, Belgium.
Crit Care Med. 2003 Sep;31(9):2339-43. doi: 10.1097/01.CCM.0000084844.95073.C0.
Levosimendan is a promising calcium sensitizer that potentially could be useful in settings of pulmonary vasoconstriction and right ventricular dysfunction. There is a shortage of information concerning its effects on right ventricular function and ventriculovascular coupling. The aim of the present study was to characterize the effects of levosimendan on right ventricular and pulmonary vascular function by means of pressure-volume and pulsatile flow analysis.
Prospective laboratory investigation.
University hospital laboratory.
Eight landrace pigs (mean weight, 37 kg).
Following instrumentation with biventricular conductance catheters, pulmonary and right coronary artery flow probes, a high-fidelity pulmonary pressure catheter, and a right coronary venous catheter, hemodynamic measurements were performed in baseline conditions and during levosimendan infusion at three increasing plasma concentrations (mean values, 27.5, 67.6, and 142.5 ng/mL).
Levosimendan increased heart rate and cardiac output, reduced systemic vascular resistance, and had a positive inotropic effect on the left ventricle and increased left ventricular mechanical efficiency. Moreover, levosimendan increased right ventricular contractility and hydraulic power. However, total pulmonary vascular resistance and characteristic impedance did not change throughout the protocol, and right ventricular mechanical efficiency decreased slightly at the highest concentration of levosimendan.
At clinical concentrations in the present model, levosimendan increases right ventricular contractility and performance without significantly influencing pulmonary vascular tone. Further studies are required in a model of pulmonary vasoconstriction to disclose possible pulmonary vasodilator effects of levosimendan.
左西孟旦是一种很有前景的钙增敏剂,可能对肺血管收缩和右心室功能障碍的情况有用。关于其对右心室功能和心室血管耦联的影响,目前信息不足。本研究的目的是通过压力-容积和搏动血流分析来描述左西孟旦对右心室和肺血管功能的影响。
前瞻性实验室研究。
大学医院实验室。
八头长白猪(平均体重37千克)。
在植入双心室电导导管、肺和右冠状动脉血流探头、高保真肺动脉导管以及右冠状动脉静脉导管后,在基线条件下以及在输注左西孟旦期间,当血浆浓度增加到三个水平(平均值分别为27.5、67.6和142.5纳克/毫升)时进行血流动力学测量。
左西孟旦增加心率和心输出量,降低全身血管阻力,对左心室有正性肌力作用,并提高左心室机械效率。此外,左西孟旦增加右心室收缩力和水力功率。然而,在整个实验过程中,总肺血管阻力和特性阻抗没有变化,在左西孟旦最高浓度时右心室机械效率略有下降。
在本模型的临床浓度下,左西孟旦增加右心室收缩力和功能,而不显著影响肺血管张力。需要在肺血管收缩模型中进行进一步研究,以揭示左西孟旦可能的肺血管舒张作用。